Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

Stock Information for IDW Media Holdings Class B

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About IDW Media Holdings Class B

Harvard Bioscience Announces Third Quarter 2025 Financial Results
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
Harvard Bioscience Appoints John Duke to Board of Directors
Harvard Bioscience Announces First Quarter 2025 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.